AlphaHunt
Healthcare

ABT Stock Analysis

Abbott Laboratories · current price $88.45 (-2.41% today)

★★★ Average 52/ Alpha Score
Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
LAST EARNINGS Abbott Laboratories (ABT)

Latest earnings

EPS
$1.26 vs $1.26 est · +0.0% vs estimate BEAT
Revenue
$11.16B · +0.2% YoY
Stock reaction (1M)
+0.5%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
52/100
Grade
C
Rev Growth YoY
+7.8%
30-day Momentum
+0.5%
Forward P/E
24.7×
Analyst Target
$116.54
Implied Upside
+31.8%

Similar stocks in Healthcare

BIIB WST LLY WAT MRNA HOLX

View all Healthcare stocks →

ABT — frequently asked

What is ABT's Alpha Score?

Abbott Laboratories (ABT) currently has a TickerMover Alpha Score of 52/100, rated ★★★ Average. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Abbott Laboratories (ABT) a buy?

TickerMover does not give buy or sell recommendations. ABT scores 52/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ABT's score updated?

ABT's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for ABT →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com